A false positive is a test result that says something is present when it actually isn’t. The test detects a condition, substance, or disease that the person doesn’t truly have. It’s the medical or scientific equivalent of a fire alarm going off when there’s no fire. False positives happen across all types of testing, from pregnancy tests and cancer screenings to drug tests and COVID diagnostics, and understanding why they occur can save you a lot of unnecessary worry.
How a False Positive Works
Every diagnostic test sorts results into categories. A true positive correctly identifies someone who has a condition. A true negative correctly identifies someone who doesn’t. A false positive is the error that happens in between: the test says “yes” when the real answer is “no.” In statistics, this is formally called a Type I error, meaning you’ve concluded something exists when it doesn’t.
No test is perfect. Every screening tool has two key properties: sensitivity (how well it catches real cases) and specificity (how well it avoids flagging people who are healthy). A test with high specificity produces fewer false positives because it’s better at correctly identifying people without the condition. When specificity drops, more healthy people get incorrectly flagged. This tradeoff is baked into every test’s design. Making a test more sensitive so it catches every possible case often means accepting a higher rate of false alarms.
Why Disease Prevalence Matters
One of the most counterintuitive facts about false positives is that the rarer a condition is in the population being tested, the more likely a positive result is wrong. This isn’t a flaw in the test itself. It’s math. When very few people in a group actually have a disease, even a small error rate produces a large number of false alarms relative to real cases, simply because so many more healthy people are being tested than sick ones.
To put numbers on this: in one analysis of a diagnostic test with fixed sensitivity and specificity, the positive predictive value (the chance a positive result is truly correct) dropped from 26% when disease prevalence was 23% down to just 11% when prevalence fell to 10%. That means at lower prevalence, roughly 9 out of 10 positive results were false. This is why mass screening programs for uncommon diseases always build in a second, more precise confirmatory test before delivering a diagnosis.
Common Examples in Medical Testing
Mammograms
Breast cancer screening is one of the most familiar sources of false positives. In the United States, about 10% of mammograms lead to a woman being called back for further testing. Of roughly 3.5 million screening mammograms analyzed in a large National Cancer Institute study, about 345,000 were false positives. That means the vast majority of callbacks don’t end in a cancer diagnosis. Additional imaging or a biopsy typically clarifies the result.
PSA Testing
Prostate cancer screening with the PSA blood test also carries a notable false positive rate. About 6% to 7% of men receive a false positive on any given screening round. Only about 25% of men who undergo a biopsy because of an elevated PSA level are actually found to have prostate cancer. When a PSA level comes back high, the typical next step is repeating the test in 6 to 8 weeks rather than jumping straight to a biopsy, because levels can rise temporarily for reasons unrelated to cancer.
Pregnancy Tests
Home pregnancy tests detect a hormone called hCG, and while they are quite accurate, false positives do occur. Causes include certain types of tumors that produce hCG on their own, kidney disease, some antidepressant medications, perimenopause or postmenopause, and even receiving a blood transfusion from someone who is pregnant. Lung cancer is the most common non-pregnancy-related condition known to trigger a false positive pregnancy test, though this is rare.
Drug Screens
Workplace and clinical urine drug tests are a frequent source of false positives because the initial screening method (immunoassay) relies on detecting chemical structures that can look similar across different substances. Over-the-counter nasal decongestant inhalers can trigger a false positive for amphetamines. Dextromethorphan, the cough suppressant found in many cold medicines, and diphenhydramine, the antihistamine in common allergy and sleep medications, can both trigger false positives for opiates. This is why a positive drug screen is supposed to be confirmed with a more precise follow-up test before any consequences are applied.
What Causes False Positives Beyond the Disease
False positives aren’t always caused by biology. Laboratory handling errors play a role too. Common pre-analytical mistakes include contamination of the sample during collection, using the wrong type of collection container, mislabeling samples, and storing or transporting specimens at incorrect temperatures. A blood sample that clots when it shouldn’t, or one drawn too close to an IV line running fluids, can produce misleading results that have nothing to do with the patient’s actual health.
Cross-reactivity is another major cause. Many screening tests work by recognizing molecular shapes rather than exact chemical identities. When a harmless substance in your body happens to share a similar shape with the target molecule, the test can’t tell the difference. This is the mechanism behind most drug test false positives and some hormonal test errors.
The Emotional and Practical Toll
A false positive is not a harmless inconvenience. Research on newborn screening programs, where babies are tested for genetic and metabolic conditions shortly after birth, shows that parents who receive a false positive result experience significant emotional distress. In one UK study, nearly two thirds of mothers said the wait for repeat test results was difficult and brought feelings of guilt and heightened anxiety. A Canadian study found parents described the period after notification as “the scariest time of their lives.”
These effects aren’t always short-lived. Six months after receiving a false positive result for a metabolic disorder, mothers in one study scored significantly higher on measures of parenting stress and parent-child relationship difficulties compared to mothers whose children had normal results. About 10% of parents reported clinically significant stress levels that persisted well beyond the resolution of the scare. A systematic review concluded that anxiety following false positives may not fully return to baseline and can linger for extended periods. Some parents became hypervigilant about their child’s health, watching for symptoms of a disease the child didn’t have, and others developed mistrust of the screening system itself.
The consequences extend beyond emotions. In the same newborn screening research, children who had received false positive results were hospitalized at twice the rate of children with normal results in the six months that followed, likely reflecting parental anxiety driving more medical visits and interventions. False positive mammograms, meanwhile, have been shown to make some women avoid future screenings altogether, potentially causing them to miss a real cancer later on.
What Happens After a Positive Result
In well-designed screening programs, a single positive result is treated as a starting point, not a diagnosis. The standard approach is confirmatory testing: a second, more precise test that uses a different method to verify or rule out the initial finding. For drug screens, this means a lab-based analysis that identifies exact molecules rather than relying on shape recognition. For cancer screenings, it typically means imaging with higher resolution or a tissue biopsy. For infections like COVID-19, a nucleic acid amplification test can confirm an antigen test result.
If you receive a positive screening result for anything, the most useful thing to understand is that the initial test was designed to cast a wide net. Its job is to avoid missing real cases, which means it intentionally accepts some false alarms. The confirmatory step is where precision takes over. A positive result on a screening test raises a question. The follow-up test answers it.